Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
Guoxiang Xie, Runqiu Jiang, Xiaoning Wang, et al.
EBioMedicine (2021) Vol. 66, pp. 103290-103290
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 111
Interactive Relationships between Intestinal Flora and Bile Acids
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8343-8343
Open Access | Times Cited: 90
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
Tingying Jiao, Yuandi Ma, Xiaozhen Guo, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1103-1119
Open Access | Times Cited: 72
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Joshua S. Fleishman, Sunil Kumar
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling
Chenxu Ge, Jun Tan, Deshuai Lou, et al.
Redox Biology (2022) Vol. 51, pp. 102274-102274
Open Access | Times Cited: 56
Bile Acid–Microbiome Interaction Promotes Gastric Carcinogenesis
Shouli Wang, Junliang Kuang, Hongwei Zhang, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 53
Effects of thiacloprid exposure on microbiota–gut–liver axis: Multiomics mechanistic analysis in Japanese quails
Biqi Han, Jiayi Li, Siyu Li, et al.
Journal of Hazardous Materials (2022) Vol. 442, pp. 130082-130082
Closed Access | Times Cited: 38
Treatment of liver fibrosis: Past, current, and future
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 6, pp. 755-774
Open Access | Times Cited: 37
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 35
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
Jieyi Wang, Dan Zheng, Fengjie Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
Rong Yang, Qian Li
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 33
Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
Mingzhe Zhu, Xue Wang, Kai Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 19
Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA/S1PR2/ZBP1/p-MLKL axis
Yang Shen, Na Chang, Weiyang Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 18
The Potential of Bile Acids as Biomarkers for Metabolic Disorders
Chang Yin, Ruqing Zhong, Weidong Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12123-12123
Open Access | Times Cited: 17
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Mesenchymal stem cell and exosome-based therapy for liver diseases: can it overcome conventional therapeutic inconsistencies?
Zahid Hussain
(2025) Vol. 4
Open Access
Metabolic restoration: Rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease
Jiannan Qiu, Fangying Xu, Hangjie Wei, et al.
International Journal of Biological Macromolecules (2025), pp. 141151-141151
Closed Access
Mitochondrial targeted therapy in MAFLD
Sien Lai, Dongsheng Tang, Juan Feng
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151498-151498
Closed Access
Decoding TGR5: A Comprehensive Review of Its Impact on Cerebral Diseases
Zehan Zhang, Yifei Zhang, Hongye Peng, et al.
Pharmacological Research (2025), pp. 107671-107671
Open Access
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome
Xianmei Gou, Lin Qin, Di Wu, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5870-5870
Open Access | Times Cited: 13
Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms
Chuanling Deng, Jingjin Pan, Hanyue Zhu, et al.
Foods (2023) Vol. 12, Iss. 23, pp. 4308-4308
Open Access | Times Cited: 13
The Correlation between NAFLD and T2DM
笑 雷
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 229-237
Closed Access
Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice
Xingming Xie, Bangyan Zhang, Shu Feng, et al.
Microbiology Spectrum (2025)
Open Access
Page 1 - Next Page

Scroll to top